Immune checkpoint inhibitors (ICIs) are associated with immune-related adverse events including myocarditis, whilst improving cancer-related outcomes. There is thus a clinical need to identify electrocardiographic manifestations of ICI-related myocarditis to guide clinical management. PubMed was searched for clinical studies and case reports describing electrocardiographic changes in patients with ICI-related myocarditis. A total of six clinical studies and 79 case reports were included. This revealed a range of presentations for patients on ICIs, including supraventricular arrhythmias, ventricular arrhythmias and heart block, and new changes of ST-T segment unrelated to coronary artery disease, ST-segment elevation or depression and T-wave...
Immune checkpoint inhibitors (ICIs) are increasingly recognised to effectuate long-lasting therapeut...
Immune checkpoint inhibitors (ICIs) are monoclonal antibodies that activate the immune system, aimin...
Immune checkpoint inhibitors (ICIs) are monoclonal antibodies that activate the immune system, aimin...
Immune checkpoint inhibitors (ICIs) are associated with immune-related adverse events including myoc...
BACKGROUND: Myocarditis is a highly morbid complication of immune checkpoint inhibitor (ICI) use tha...
Myocarditis is a highly morbid complication of immune checkpoint inhibitor (ICI) use that remains in...
Myocarditis is a highly morbid complication of immune checkpoint inhibitor (ICI) use that remains in...
International audienceBackground Myocarditis is a highly morbid complication of immune checkpoint in...
International audienceBackground Myocarditis is a highly morbid complication of immune checkpoint in...
Background Myocarditis is a highly morbid complication of immune checkpoint inhibitor (ICI) use that...
Background Myocarditis is a highly morbid complication of immune checkpoint inhibitor (ICI) use that...
Background Myocarditis is a highly morbid complication of immune checkpoint inhibitor (ICI) use that...
Immune checkpoint inhibitors (ICIs) are increasingly recognised to effectuate long-lasting therapeut...
Immune checkpoint inhibitors (ICIs) are increasingly recognised to effectuate long-lasting therapeut...
Immune checkpoint inhibitors (ICIs) are increasingly recognised to effectuate long-lasting therapeut...
Immune checkpoint inhibitors (ICIs) are increasingly recognised to effectuate long-lasting therapeut...
Immune checkpoint inhibitors (ICIs) are monoclonal antibodies that activate the immune system, aimin...
Immune checkpoint inhibitors (ICIs) are monoclonal antibodies that activate the immune system, aimin...
Immune checkpoint inhibitors (ICIs) are associated with immune-related adverse events including myoc...
BACKGROUND: Myocarditis is a highly morbid complication of immune checkpoint inhibitor (ICI) use tha...
Myocarditis is a highly morbid complication of immune checkpoint inhibitor (ICI) use that remains in...
Myocarditis is a highly morbid complication of immune checkpoint inhibitor (ICI) use that remains in...
International audienceBackground Myocarditis is a highly morbid complication of immune checkpoint in...
International audienceBackground Myocarditis is a highly morbid complication of immune checkpoint in...
Background Myocarditis is a highly morbid complication of immune checkpoint inhibitor (ICI) use that...
Background Myocarditis is a highly morbid complication of immune checkpoint inhibitor (ICI) use that...
Background Myocarditis is a highly morbid complication of immune checkpoint inhibitor (ICI) use that...
Immune checkpoint inhibitors (ICIs) are increasingly recognised to effectuate long-lasting therapeut...
Immune checkpoint inhibitors (ICIs) are increasingly recognised to effectuate long-lasting therapeut...
Immune checkpoint inhibitors (ICIs) are increasingly recognised to effectuate long-lasting therapeut...
Immune checkpoint inhibitors (ICIs) are increasingly recognised to effectuate long-lasting therapeut...
Immune checkpoint inhibitors (ICIs) are monoclonal antibodies that activate the immune system, aimin...
Immune checkpoint inhibitors (ICIs) are monoclonal antibodies that activate the immune system, aimin...